CONTACT: Alli Pearson, Neogen Corporation, 517/372-9200 LANSING, Mich., Sept. 8, 2017 — Neogen Corporation has developed AccuClean® Advanced, an enhanced rapid protein test that delivers industry-leading speed and sensitivity for determining the cleanliness of food contact surfaces and equipment. AccuClean Advanced is a simple, 10-second visual test that reveals detected protein residue through an easy-to-interpret color... Read more
(Chelmsford, MA – Thursday, September 7, 2017) The new MiniLab EL Series from Spectro Scientific is a fast, convenient oil analysis tool for non-destructive testing of high performance engines in aircraft, racing cars, and railway environments. Oil analysis is a reliable and mature non-destructive testing technique that is widely used in engine design and development, production quality... Read more
Investment from leading technology and healthcare investors will accelerate the growth of the global platform for genomic data The global platform aims to empower institutions and individuals to realize the full value of their genomic data – to benefit human health and contribute to advancing precision medicine SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Sept. 7, 2017 /PRNewswire/ — WuXi NextCODE,... Read more
VENLO Netherlands, September 6, 2017 – The Management Board of QIAGEN N.V.(“QIAGEN” or the “Company”), with the consent of its Supervisory Board has resolved today to issue senior, unsecured cash settled convertible notes convertible into common shares of the Company (the “Notes”). The Company intends to place Notes in an aggregate volume of USD 350 million. The... Read more
VENLO, the Netherlands, September 6, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announces the successful completion of the following series of transactions: The issue of new senior unsecured cash settled convertible notes (the “Notes“) outside the United States for $400 million aggregate principal amount; and The entry into derivative transactions to increase... Read more
MINNEAPOLIS, Sept. 6, 2017 /PRNewswire/ — R&D Systems®, a Bio-Techne brand, announced today the release of a new rapid, solid phase, enzyme-linked immunosorbent assay (ELISA) designed to measure anti-Zika virus immunoglobulin G (IgG) antibodies in human serum. A unique feature of this assay is that, prior to performing the test, samples are pre-treated with a proprietary... Read more
Cambridge, UK, September 06, 2017 Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensed Congenica’s Sapientia™ software platform to perform analysis of whole-exome sequencing data and... Read more
D8 DISCOVER Plus Chiba, Japan – September 06, 2017 – At the Japan Analytical Scientific Instruments Show (JASIS), Bruker announces the new D8 DISCOVER PlusTM X-ray diffraction (XRD) system. The D8 DISCOVER Plus combines the high power of the new TXS-HETM high-efficiency Turbo X-ray SourceTM with the unrivaled reliability and accuracy of the new high endurance ATLASTM goniometer. The TXS-HE is optimized to deliver an extremely high intensity X-ray... Read more
SCIEX CE Trusted By Biopharma Laboratories and Manufacturers of Therapeutic Monoclonal Antibodies worldwide September 06, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today that the SCIEX PA 800 Plus Pharmaceutical Analysis System is now used by virtually all manufacturers of commercial therapeutic monoclonal antibodies. The SCIEX PA 800 Plus runs various methods... Read more
SEPTEMBER 05, 2017 MINNEAPOLIS, Sept. 5, 2017 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Trevigen Inc. for cash. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “We are pleased to have Trevigen as... Read more